---
schema_version: "secwatch.filing_event.v1"
accession: "0001110803-25-000014"
form_type: "8-K"
ticker: "ILMN"
cik: "0001110803"
company_name: "ILLUMINA, INC."
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:24:58.920143+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Illumina Q4 core revenue up 1% to $1.1B; FY2025 guided to low single-digit growth

## Summary
- Core Illumina Q4 revenue $1.104B (+1% YoY); GAAP EPS $0.73, non-GAAP EPS $0.95.
- Full year core revenue $4.332B (-2% YoY); free cash flow $1.07B.
- FY2025 guidance: core revenue $4.28B-$4.4B; non-GAAP Op margin ~23%; non-GAAP EPS $4.50-$4.65.
- China Ministry of Commerce impact excluded from guidance; company notes current macro/political environment.
- Key partnerships announced: NVIDIA, UK Biobank proteomics, Regeneron/Truveta Genome Project.

## SEC filing metadata
- accession: 0001110803-25-000014
- form_type: 8-K
- ticker: ILMN
- cik: 0001110803
- company_name: ILLUMINA, INC.
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1110803/000111080325000014/0001110803-25-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1110803/000111080325000014/ilmn-20250206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001110803-25-000014
- JSON: https://secwatch.observer/filing/0001110803-25-000014.json
- Plain text: https://secwatch.observer/filing/0001110803-25-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.